IRCT2016070728821N1已完成未知
Clinical and biochemical Aspirin desensitization effectiveness assay in patients with nasal polyposis and aspirin sensitive asthma
Vice chancellor for research, Shahid Beheshti University of Medical Sciences0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •chronic rhinosinusitis (CRS) with nasal polyposis patients more than 18 years old that is admitted in allergy clinic. CRS diagnose criteria:(1) 2 or more of symptoms: nasal congestion; pain or pressure of face; post or anterior discharge; loss of smell. (2) Symptoms should stay more than 12 week. CRS with nasal polyposis diagnose will confirm by CT SCAN or endoscopy of sinus.
- •Exclusion criteria: Forced expiratory volume at first second less than 70% in spirometry; gastrointestinal bleeding; pregnancy or breast feeding; Anaphylaxy to Nonsteroidal anti inflammatory drugs (NSAID); Myocardial infarction or stroke in last 6 month and sever liver or kidney disease.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Study of the prevalence of aspirin sensitivity in patients with chronic rhinosinusitis and nasal polyposis coming to allergy department of Rasool-e-Akram hospital according to response to standard treatment after three months.chronic rhinosinusitis with nasal polyposis.Other polyp of sinus Polyp of sinus: accessory ethmoidal maxillary sphenoidalIRCT2015061322531N1Vce chancellor for research of Iran University of Medical Sciences100
已完成
4 期
The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory DiseasesAsthma, Aspirin-InducedNCT01867281Tehran University of Medical Sciences32
已完成
不适用
Prevalence of aspirin sensitivity in moderate to severe asthma according to the response to 3 months asthma standard therapyAsthma.Mixed asthma Combination of conditions listed in J45.0 and J45.1IRCT2015042721970N1Vice chancellor for research, Iran Uiversity of Medical Sciences100
进行中（未招募）
1 期
The Pharmacogenetics of Aspirin Resistance - The Pharmacogenetics of Aspirin ResistanceAspirin resistance: Vascular diseases are common problems and aspirin is used as an anti-platelet drug to prevent thrombosis. However, aspirin's anti-platelet effect may not be uniform in all patients. From a biochemical perspective, aspirin resistance refers to patients who do not display an adequate degree of platelet inhibition on formal laboratory tests. Published data suggest that 5 - 45% of patients are 'aspirin resistant'. The mechanisms of aspirin resistance are poorly understood.EUCTR2006-001232-42-GBRoyal Group of Hospitals Trust150
招募中
Unknown
Effectiveness of aspirin in children undergoing heart surgeryAspirin resistanceCardiovascular - Other cardiovascular diseasesCongenital heart diseaseACTRN12623001208695Children's Health Queensland Hospital and Health Service132